APC and neoplasm: Considering these findings, tankyrase inhibition may not always be effective at reducing WNT/β-catenin signaling in tumors that harbor mutations in the APC gene and that alternative tankyrase dependent cellular effects may be responsible for the anti-tumor properties of tankrase inhibition in sensitive tumors where WNT/β-catenin signaling is unchanged.